Skip to main contentBack to Top

Researchers in the Cancer Immunology, Inflammation and Tolerance program use a range of techniques to study how the immune system influences tumorigenesis and cancer therapy. The immune system can inhibit or promote tumor progression in local tissues where pre-malignancies form. Major program themes are to elucidate

  • How pre-malignancies create and sustain local immunologic tolerance necessary for tumor formation
  • How to destroy local tolerance that protects tumors from natural and vaccine-induced anti-tumor immunity.

The scientific rationale for this dual approach is that pre-malignant cells create and sustain tolerance during tumor progression, while breaking tumor-associated tolerance is necessary for successful anti-tumor treatment. Hence, program goals are to elucidate molecular and cellular pathways at sites of inflammation that promote or break immune tolerance using pre-clinical mouse models of tumor progression and autoimmune syndromes, and developing novel immunotherapies to treat these syndromes more effectively by targeting tolerance pathways. To this end, program faculty also engage in promoting pre-clinical research and early-phase clinical trials of novel vaccine adjuvants to improve cancer immunotherapy, in some cases with corporate partners.

To pursue these focused research themes and scientific goals, program faculty employ many state-of-the-art techniques, facilities, and unique resources, including flow cytometric sorting and analysis, a range of molecular imaging techniques, genomic analysis, and genetically modified mouse strains. Future program development will build on existing CIT program strengths by recruiting new investigators with expertise in inflammation, immunological, and metabolic research to complement current research focused on regulation of adaptive immunity.

Program Members

photo of Jennifer W. Bradford, PhD

Jennifer W. Bradford, PhD

  • Assistant Professor
photo of Yan Cui, PhD

Yan Cui, PhD

  • Professor
photo of Yukai He, MD, PhD

Yukai He, MD, PhD

  • Professor
photo of Theodore S. Johnson, MD, PhD

Theodore S. Johnson, MD, PhD

  • Associate Professor
photo of Zoya C. Kurago, DDS, PhD

Zoya C. Kurago, DDS, PhD

  • Associate Professor
photo of Kebin Liu, PhD

Kebin Liu, PhD

  • Professor
photo of Santhakumar Manicassamy, PhD

Santhakumar Manicassamy, PhD

  • Associate Professor
photo of David Munn, MD

David Munn, MD

  • Professor
photo of Nagendra Singh, PhD

Nagendra Singh, PhD

  • Assistant Professor
photo of Gang Zhou, PhD

Gang Zhou, PhD

  • Associate Professor

Cancer Research News

Man in black coat and shirt leans against building

Moore recognized with AACR Minorities in Cancer Research award

Dr. Justin Xavier Moore has been recognized with an American Association for Cancer Research Minorities in Cancer Research award.

Colon Cancer Awareness Month ribbon in front of picture of the Georgia Cancer Center

Oncology professor answers questions regarding National Colon Cancer Awareness Month

"Colon cancer is largely preventable if patients undergo screening tests, like a surveillance colonoscopy starting at 45 years or earlier depending on family history."

photo from article Georgia Cancer Center researcher works to develop new treatment options for liver cancer

Georgia Cancer Center researcher works to develop new treatment options for liver cancer

Despite liver cancer being the third leading cause of cancer deaths worldwide, there are not many treatment options currently available for patients. Dr. Yukai He and his team want to change that.

People standing hold a big check

Paceline donates $330,069 to advance research projects at Georgia Cancer Center

This year’s fundraising total represents a 65% increase since its inaugural event held in May 2019.